User login
Photo by Charles Haymond
Haemonetics Corporation is recalling all lots of the Leukotrap RC System with RC2D Filter (re-order numbers 129-62 and 129-63) distributed since April 14, 2016.
The company says using these lots of the blood collection system may result in a higher-than-expected level of leukocytes in transfused blood.
Earlier this month, Haemonetics recalled 3 lots of the Leukotrap RC System with RC2D Filter due to reports of higher-than-expected residual white blood cells.
Since then, the company has received additional reports related to other lots.
Blood products that have been processed with the lots distributed since April 14, 2016, should not be re-filtered and should be labeled as non-leukoreduced, unless individual units have been tested and found suitable to be labeled as leukoreduced.
Continued use of these lots will require customers to verify that each unit labeled as leukoreduced was tested and meets standards for residual white blood cells acceptable to the US Food and Drug Administration.
Customers who want to return unused product to Haemonetics should contact their local customer service representative. 
Photo by Charles Haymond
Haemonetics Corporation is recalling all lots of the Leukotrap RC System with RC2D Filter (re-order numbers 129-62 and 129-63) distributed since April 14, 2016.
The company says using these lots of the blood collection system may result in a higher-than-expected level of leukocytes in transfused blood.
Earlier this month, Haemonetics recalled 3 lots of the Leukotrap RC System with RC2D Filter due to reports of higher-than-expected residual white blood cells.
Since then, the company has received additional reports related to other lots.
Blood products that have been processed with the lots distributed since April 14, 2016, should not be re-filtered and should be labeled as non-leukoreduced, unless individual units have been tested and found suitable to be labeled as leukoreduced.
Continued use of these lots will require customers to verify that each unit labeled as leukoreduced was tested and meets standards for residual white blood cells acceptable to the US Food and Drug Administration.
Customers who want to return unused product to Haemonetics should contact their local customer service representative.
Photo by Charles Haymond
Haemonetics Corporation is recalling all lots of the Leukotrap RC System with RC2D Filter (re-order numbers 129-62 and 129-63) distributed since April 14, 2016.
The company says using these lots of the blood collection system may result in a higher-than-expected level of leukocytes in transfused blood.
Earlier this month, Haemonetics recalled 3 lots of the Leukotrap RC System with RC2D Filter due to reports of higher-than-expected residual white blood cells.
Since then, the company has received additional reports related to other lots.
Blood products that have been processed with the lots distributed since April 14, 2016, should not be re-filtered and should be labeled as non-leukoreduced, unless individual units have been tested and found suitable to be labeled as leukoreduced.
Continued use of these lots will require customers to verify that each unit labeled as leukoreduced was tested and meets standards for residual white blood cells acceptable to the US Food and Drug Administration.
Customers who want to return unused product to Haemonetics should contact their local customer service representative.